People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other Health Care, Business Services, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Shape Medical Systems, Inc. | — | Other Health Care | Series A | $8.3M | $167.9M | 2012 |
| Triple Dot Reprise, Inc. | — | Business Services | Seed | $2.5M | $63.0M | 2011 |
| Macrotope, Inc. | — | Pharmaceuticals | Pre-Seed | $900K | $1.1M | 2022 |
| Zuvachem Inc | — | Other | Pre-Seed | $168K | $3.9M | 2009 |
Stephen Anderson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Anderson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Philip Goelet | 1 | 3 |
| Andrew Hofmeister | 1 | 3 |
| Michael Spearman | 1 | 2 |
| Cheryl Ingoe | 1 | 2 |
| Kathleen Miller | 1 | 2 |
| Neil Vogel | 1 | 2 |
| Gary Colen | 1 | 1 |
| Clarence Johnson | 1 | 1 |
| Elliot Camptbell | 1 | 1 |
| Elliot Campbell | 1 | 1 |
| Daniel Spearman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.